Wellington Management Group LLP Decreases Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Wellington Management Group LLP reduced its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 8.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,462,339 shares of the company's stock after selling 591,060 shares during the quarter. Wellington Management Group LLP owned 2.62% of HCA Healthcare worth $1,939,671,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of HCA. Whipplewood Advisors LLC acquired a new stake in shares of HCA Healthcare in the fourth quarter valued at approximately $31,000. Tidemark LLC acquired a new stake in shares of HCA Healthcare in the 4th quarter valued at approximately $36,000. Legacy Investment Solutions LLC acquired a new position in HCA Healthcare during the third quarter worth $39,000. Activest Wealth Management grew its position in shares of HCA Healthcare by 1,250.0% in the 4th quarter. Activest Wealth Management now owns 135 shares of the company's stock valued at $40,000 after acquiring an additional 125 shares during the period. Finally, Pinnacle Bancorp Inc. raised its stake in HCA Healthcare by 50.0% in the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company's stock valued at $45,000 after buying an additional 50 shares during the period. Institutional investors and hedge funds own 62.73% of the company's stock.

Insider Buying and Selling at HCA Healthcare

In related news, SVP Jennifer Berres sold 9,533 shares of the business's stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the transaction, the senior vice president now directly owns 15,412 shares of the company's stock, valued at approximately $4,971,757.08. The trade was a 38.22 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 1.30% of the company's stock.

Remove Ads

Wall Street Analyst Weigh In

HCA has been the subject of several research reports. KeyCorp cut their price target on HCA Healthcare from $420.00 to $370.00 and set an "overweight" rating for the company in a report on Tuesday, January 7th. Truist Financial reduced their target price on shares of HCA Healthcare from $430.00 to $390.00 and set a "buy" rating for the company in a report on Monday, January 6th. Cantor Fitzgerald restated an "overweight" rating and set a $405.00 price objective on shares of HCA Healthcare in a research report on Monday, January 27th. Morgan Stanley lowered their target price on HCA Healthcare from $406.00 to $355.00 and set an "equal weight" rating on the stock in a research note on Tuesday, December 17th. Finally, Royal Bank of Canada decreased their price objective on HCA Healthcare from $405.00 to $384.00 and set an "outperform" rating on the stock in a report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $385.67.

HCA Healthcare Trading Up 0.5 %

Shares of HCA traded up $1.75 during mid-day trading on Wednesday, reaching $347.48. 1,249,318 shares of the company were exchanged, compared to its average volume of 1,347,916. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14. The business has a 50 day simple moving average of $325.79 and a two-hundred day simple moving average of $340.25. The stock has a market capitalization of $85.55 billion, a PE ratio of 15.82, a PEG ratio of 1.10 and a beta of 1.68.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period last year, the firm earned $5.90 EPS. On average, analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 31st. Shareholders of record on Monday, March 17th were issued a dividend of $0.72 per share. This is a positive change from HCA Healthcare's previous quarterly dividend of $0.66. This represents a $2.88 dividend on an annualized basis and a yield of 0.83%. The ex-dividend date was Monday, March 17th. HCA Healthcare's payout ratio is currently 13.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.